OC
GOSS icon

Oppenheimer & Co’s Gossamer Bio GOSS Stock Holding History

Oppenheimer & Co’s Portfolio GOSS Stock Details GOSS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.14K Hold
13,000
– – ﹤0.01% 1758
2026
Q1 		$4.27K Sell
13,000
-24,500
-65% -$38.5K ﹤0.01% 1680
2025
Q4 		$116K Buy
+37,500
New +$107K ﹤0.01% 1487

Other funds holding GOSS

D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
6CM
683 Capital Management New York $2.04B AUM 94.26% 1-Year Est. Return
DIG
DeepCurrents Investment Group New York $3.3B AUM 12.57% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $5.15B AUM 1.28% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $44.3M AUM 34.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
WAM
Wolverine Asset Management Chicago, Illinois $11.4B AUM 5.65% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
KCM
Kalehua Capital Management Dallas, Texas $174M AUM

Oppenheimer & Co's GOSS Position: Q2 2026 in Review

Oppenheimer & Co held its Gossamer Bio (GOSS) position steady in Q2 2026 at 13,000 shares worth $2.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1758.

Oppenheimer & Co first reported a position in GOSS in Q4 2025 and has held it in 3 quarters since. The position peaked at $116K in Q4 2025. 170 funds tracked by Wall St. Rank hold GOSS as of Q2 2026.

  • Oppenheimer & Co held 13,000 shares of Gossamer Bio worth $2.14K as of Q2 2026.
  • Oppenheimer & Co left its Gossamer Bio share count unchanged in Q2 2026.
  • Gossamer Bio made up ﹤0.01% of Oppenheimer & Co's portfolio in Q2 2026, its #1758 holding.
  • Oppenheimer & Co first reported a position in Gossamer Bio in Q4 2025 and has held it in 3 quarters since.
  • Oppenheimer & Co's Gossamer Bio position peaked at $116K in Q4 2025.
  • 170 funds tracked by Wall St. Rank held Gossamer Bio as of Q2 2026.

Based on Oppenheimer & Co's 13F filing for Q2 2026, filed 3 Aug 2026.